1 year return (CAGR)
-50.41%
Compass Therapeutics Inc. Exchange (NASDAQ, USD)
CMPX
1.83
-0.02 (-1.08%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-6.79%
5 year return (CAGR)
-12.16%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
329.56M
Price/Sales
-
Ent value
318.23M
Price/Book
1.98
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-5.72%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.87 |
| Daily high | 1.90 |
| Daily low | 1.80 |
| Daily Volume | 2.24M |
| All-time high | 8.80 |
| 1y analyst estimate | 8.92 |
| Beta | 0.84 |
| EPS (TTM) | -0.39 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 27 Feb 2026 |
Downside potential
Loading...
Downside potential data
| CMPX | S&P500 | |
| Current price drop from All-time high | -79.20% | -3.06% |
| Highest price drop | -90.91% | -56.47% |
| Date of highest drop | 5 Jul 2024 | 9 Mar 2009 |
| Avg drop from high | -67.11% | -10.68% |
| Avg time to new high | 334 days | 12 days |
| Max time to new high | 1332 days | 1805 days |
News
